17 December 2012 | News | By BioSpectrum Bureau
New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order worth $34 million (Rs 187.61 crore) for the supply of 345 million doses of Trivalent Oral Polio Vaccines (tOPV).
The company will supply the doses between December 2012 and May 2013 to meet the demands of national immunization days. Panacea will supply 125 million doses of tOPV in December 2012 and another 70 million doses for January.
"We are pleased with this opportunity to mee the demands of NIDs and SNIDs programs. These programs have played a major role in eradication of polio in this countrym" said Dr Rajesh Jain, joint managing director of Panacea, while commenting on the development.